Alfuzosin clinical trials
Also written Xatral and SL770499.
How each study uses alfuzosin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the alfuzosin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 12 Jun 2003 · UROXATRAL · NDA 021287 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
35 studies that test it; most in 2006 (11)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 11 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 21 · Other 14
Sanofi (18) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Samsung Medical Center (1) · University Hospitals Cleveland Medical Center (1) · Asan Medical Center (1) · Mayo Clinic (1) · Chesapeake Urology Research Associates (1) · Kocatepe University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses alfuzosin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 35
- Multiple Dose, Bioequivalence Study of Generic Alfuzosin Hydrochloride 10 mg Prolonged-release Tablets Under Fed ConditionsNot yet recruitingPhase 1Pharma NuevaNCT06316336Written as Alfuzosin Hydrochloride 10 mgHow we know
- The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed ConditionsNot yet recruitingPhase 1International Bio serviceNCT06228339Written as Alfuzosin Hydrochloride 10 mg Prolonged-release TabletsHow we know
- Evaluation of Symptom-specific Goal AchievementCompletedPhase 4Samsung Medical CenterNCT00836823Written as AlfuzosinHow we know
- Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)CompletedNot applicableUniversity Hospitals Cleveland Medical CenterNCT00256399Written as Alfuzosin 10 mgHow we know
- The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH PatientsCompletedPhase 4Asan Medical CenterNCT00696761Written as AlfuzosinHow we know
- Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00103402Written as AlfuzosinHow we know
- Effects of Alpha-1 Antagonist, Stress and Relaxation on Anorectal FunctionsCompletedPhase 2Mayo ClinicNCT01834729Written as AlfuzosinHow we know
- An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract SymptomsCompletedPhase 3Chesapeake Urology Research AssociatesNCT00893113Written as AlfuzosinHow we know
- The Effects of α-adrenergic Receptor Antagonists on Choroid and PupilCompletedPhase 4Kocatepe UniversityNCT03144596Written as Alfuzosin Hydrochloride 10 MGHow we know
- Use of Alfuzosin in Stone Treatment With ESWLWithdrawnPhase 3Singapore General HospitalNCT00388271Written as Alfuzosin (Xatral)How we know
- A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney StonesWithdrawnNot applicableUnity Health TorontoNCT00583258Written as Alfuzosin (Xatral)How we know
- Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCompletedPhase 3SanofiNCT00549939Written as AlfuzosinHow we know
- Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyCompletedPhase 3SanofiNCT00576823Written as AlfuzosinHow we know
- Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male VolunteersCompletedPhase 1Boehringer IngelheimNCT02266537Written as AlfuzosinHow we know
- Alfuzosin Hydrochloride to Relieve Ureteral Stent DiscomfortCompletedPhase 3University of MinnesotaNCT00467467Written as Alfuzosin HydrochlorideHow we know
- Alfuzosin for Medical Expulsion Therapy of Ureteral StonesStatus unknownPhase 3United States Naval Medical Center, San DiegoNCT00713739Written as AlfuzosinHow we know
- Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)TerminatedPhase 2/3Nova Scotia Health AuthorityNCT00688948Written as AlfuzosinHow we know
- ALF-ONE : ALFuzosin ONcE DailyCompletedPhase 4SanofiNCT00280605Written as AlfuzosinHow we know
- Benign Prostatic Hyperplasia in TaiwanCompletedNot applicableSanofiNCT00941343Written as Alfuzosin (XATRAL® - SL770499)How we know
- Minimally Invasive Surgical Therapy for BPHTerminatedPhase 3National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00064649Written as Finasteride and AlfuzosinHow we know
See all 35 studies that test alfuzosin →
Given beside what is tested · 1 — alfuzosin is usual care or a partner of the new treatment
Codes
What other systems call alfuzosin · ClinicalTrials.gg INT003252
- MeSH (NLM) C047638alfuzosinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 90347YTW5FALFUZOSINConfirmed FDA, NLM, Wikidata
- RxNorm 17300Confirmed FDA, Wikidata
- Wikidata Q2736873alfuzosinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61627AlfuzosinOne source FDA
- DrugBank DB00346One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C047638 | alfuzosin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 90347YTW5F | ALFUZOSIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 17300 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2736873 | alfuzosin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61627 | Alfuzosin | One source FDA |
| DrugBank | DB00346 | — | One source Wikidata |
Also registered as alfuzosin hydrochloride (UNII 75046A1XTN · RxNorm 46043).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.